United Therapeutics Corp (NASDAQ:UTHR)

CAPS Rating: 4 out of 5

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

Recs

0
Player Avatar pzarker (66.79) Submitted: 11/27/2006 2:06:38 AM : Outperform Start Price: $28.98 UTHR Score: +51.99

To be honest, this is a "gut feeling" pick, i feel that their is potential here to get back up to their 52 week high level.

Featured Broker Partners


Advertisement